{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963018",
  "id": "02963018",
  "pages": 24,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1501",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l5zyqgrjb8z9.pdf",
  "summary": "### **Tetratherix Pty Ltd \u2013 Interim Financial Report (31 Dec 2024) \u2013 Material Information Summary**  \n\n#### **Financial & Operational Highlights**  \n- **Net loss**: $2.08M (vs. $1.33M prior half-year).  \n- **Cash balance**: $9.22M (up from $126k at 30 June 2024).  \n- **Revenue**: $458.7k (primarily R&D grants; down from $545.8k YoY).  \n- **Net liabilities**: $8.42M (worsened from $6.78M at 30 June 2024).  \n\n#### **Capital Structure & Funding Risk**  \n- **Going concern reliance**: Contingent on successful **IPO** within 12 months.  \n  - **Backup plan**: Contingency funding strategy extends to Q3 FY2026 if IPO delayed.  \n- **Recent funding**:  \n  - **Convertible notes issued**: $7.32M (8% interest).  \n  - **SAFE notes issued**: $2.97M (fair value adjustments led to $422k loss).  \n- **NSW Medical Device Fund loan**: $1.8M (non-current; CPI-linked interest).  \n\n#### **Post-Reporting Date Developments**  \n- **Corporate restructuring**: Company converted to unlisted public entity (Tetratherix Limited) on 25 March 2025.  \n- **New subsidiary**: Tetratherix BTX Pty Ltd incorporated (3 April 2025).  \n\n#### **Valuation & Liquidity Risks**  \n- **Material uncertainty**: Auditor notes doubt over going concern due to losses and reliance on IPO.  \n- **Key liabilities**:  \n  - **Preference shares**: $5.71M (convertible to equity at IPO).  \n  - **Lease liabilities**: $242k (current + non-current).  \n\n#### **Equity & Dilution**  \n- **Shares issued**: 4,431 ordinary shares ($0.50/share) via option exercise (Dec 2024).  \n- **Basic EPS**: -5.50 cents/share (vs. -3.78 cents YoY).  \n\n**No material dividend, capex commitments, or contingent liabilities disclosed.**  \n\n**Priority Note**: IPO execution is critical\u2014failure may trigger liquidity crisis and require alternative funding.",
  "usage": {
    "prompt_tokens": 10484,
    "completion_tokens": 488,
    "total_tokens": 10972,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T05:18:23.285141"
}